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Background: To compare the predictability of the Framingham Risk Score (FRS), United Kingdom Prospective Diabetes 
Study (UKPDS) risk engine, and the Systematic Coronary Risk Evaluation (SCORE) for carotid atherosclerosis and 
peripheral arterial disease in Korean type 2 diabetic patients. 
Methods: Among 1,275 registered type 2 diabetes patients in the health center, 621 subjects with type 2 diabetes 
participated in the study. Well-trained examiners measured the carotid intima-media thickness (IMT), carotid plaque, 
and ankle brachial index (ABI). The subject’s 10-year risk of coronary heart disease was calculated according to the FRS, 
UKPDS, and SCORE risk scores. These three risk scores were compared to the areas under the curve (AUC).
Results: The odds ratios (ORs) of all risk scores increased as the quartiles increased for plaque, IMT, and ABI. For plaque 
and IMT, the UKPDS risk score provided the highest OR (95% confidence interval) at 3.82 (2.36, 6.17) and at 6.21 (3.37, 
11.45). For ABI, the SCORE risk estimation provided the highest OR at 7.41 (3.20, 17.18). However, no significant difference 
was detected for plaque, IMT, or ABI (P = 0.839, 0.313, and 0.113, respectively) when the AUCs of the three risk scores were 
compared. When we graphed the Kernel density distribution of these three risk scores, UKPDS had a higher distribution 
than FRS and SCORE.
Conclusion: No significant difference was observed when comparing the predictability of the FRS, UKPDS risk engine, and 
SCORE risk estimation for carotid atherosclerosis and peripheral arterial disease in Korean type 2 diabetic patients. 
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￿erefore we investigated the association between these risk scores 
(FRS, UKPDS, and SCORE) and surrogate measures of CVD, 
such as carotid plaque, CCA-IMT, and ABI. Also we compared the 
predictability of these risk scores for carotid plaque, CCA-IMT and 
ABI in Korean type 2 diabetic patients.
METHODS
1. Study Subjects
Between October 2008 and June 2009, out of 1,275 registered 
type 2 diabetes patients in the public health center of Seo-gu, 
Gwangju and Gokseng-gun, Jeollanamdo, Korea, 709 subjects with 
type 2 diabetes chose to participate in this study. ￿e response rate 
for this study was 55.6%. Seventy-eight subjects who had a history 
of CVD, and 10 subjects who did not provide a blood sample 
were excluded from the study. In total, 621 patients participated 
in this study. This study was conducted in accordance with the 
Declaration of Helsinki guideline. ￿e study protocol was approved 
by the Institutional Review Board of Chonnam National University 
Hospital (IRB number for Seo-gu, Gwangju: I-2008-11-135, IRB 
number for Gokseng-gun, Jeollanamdo: I-2009-07-069), and 
informed consent was obtained from each subject.
Well-trained examiners interviewed the patients using a 
questionnaire that included items regarding cigarette smoking, 
consumption of alcohol, physical activity, duration of diabetes, 
diabetes complications, and hypertension medication.
Weight was measured to the nearest 0.1 kg while the subjects 
wore light clothes and height was measured to the nearest 0.1 cm in 
stocking feet. Abdominal circumference was measured to the nearest 
0.1 cm at expiration through a horizontal plane around the abdomen 
at the level of the midpoint between the lowest rib and the iliac 
crest. Blood pressure was measured twice with a standard mercury 
sphygmomanometer a￿er resting for at least 5 minutes.
After an overnight fast, venous blood was sampled and se rum 
was separated on-site and stored at -70
oC until analysis. Con-
centrations of total cholesterol, high-density lipoprotein cholesterol, 
and triglycerides were analyzed using enzymatic methods. All sera 
were measured using an automatic analyzer (HITACHI-7600, 
Hitachi Ltd., Tokyo, Japan). LDL cholesterol was calculated using the 
equation proposed by Friedewald et al.,
16) except when triglycerides 
exceeded 400 mg/dL, in which case the data were treated as 
INTRODUCTION
In the 20th century, cardiovascular disease (CVD) became the 
main cause of mortality and morbidity in Western populations, and 
the global prevalence of diabetes was estimated at 171 million in 
2000.
1) ￿e risk of coronary artery disease is six times higher in type 
2 diabetes patients than in the general population.
2,3) Therefore, to 
control CVD risk factors and lower the disease burden of diabetes, 
a method devised to estimate the risk of CVD in diabetes patients is 
highly necessary.
Several surrogate measures for CVD that can estimate subclinical 
atherosclerosis have been developed. Common carotid artery 
intima-media thickness (CCA-IMT) is known to be correlated 
with coronary artery disease, stroke, and several other risk factors.
4-6) 
Carotid plaque has different pathogenic characteristics compared 
to IMT; however, both IMT and carotid plaque share a common 
association with atherosclerosis and ischemic heart.
7,8) The ankle–
brachial index (ABI) is an easy method for measuring peripheral 
arterial disease (PAD) and is commonly used to screen peripheral 
vascular disease in patients with diabetes.
9)
Wilson et al.
10) estimated the risk of CVD using data from the 
Framingham heart study. The Framingham Risk Score (FRS) was 
developed to predict the incident risk of CVD according to age, low-
density lipoprotein (LDL) levels, high-density lipoprotein (HDL) 
levels, smoking, and hypertension. Because very few diabetes patients 
were included in this previous study, some uncertainty remains 
according the accuracy of the FRS to predict CVD risk in diabetes 
patients.
11)  On the other hand, some European studies have reported 
that the FRS overestimates CVD risk in the general European 
population.
12-14) To correct this overestimation, the Systematic 
Coronary Risk Evaluation (SCORE) project was initiated to develop 
an appropriate risk estimation method for the general European 
population.
15) In 2001, the United Kingdom Prospective Diabetes 
Study (UKPDS) risk engine was published based on data from 
5,102 newly diagnosed type 2 patients who were followed-up for an 
average of 10.4 years. ￿e UKPDS includes the duration of diabetes 
and glycated hemoglobin (HbA1c) level as variables, thus allowing it 
address the risk of CVD speci￿cally in diabetes patients.
Even though these risk scores were developed and used for 
controlling CVD risk factors, we do not know which risk score would 
be￿er predict future CVD events in Korean type 2 diabetic patients. Hye-Ran Ahn, et al: Comparison of Risk Scores for Predicting Atherosclerosis Hye-Ran Ahn, et al: Comparison of Risk Scores for Predicting Atherosclerosis Hye-Ran Ahn, et al: Comparison of Risk Scores for Predicting Atherosclerosis
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was de￿ned as the CCA-IMT.
A￿er at least 5-minute rest, the ABI was automatically calculated 
in the supine position using aVP-1000 system (Colin Co, Komaki, 
Japan), with cu￿s around both the arms and ankles. If any of the ABIs 
were less than 0.9, the patient was de￿ned as having PAD. 
3. FRS, UKPDS, and SCORE Risk Equations
The FRS was calculated using the equation for estimating 10-
year CHD risk.
10) ￿e UKPDS risk engine (ver. 2.0) for 10-year fatal 
CHD risk was downloaded from the website,
17) and used to analyze 
the data. ￿e 10-year fatal CHD SCORE risk score for the high risk 
group was used to analyze our data, as previously described.
15) ￿e 
components of these risk equations are listed in Table 1.
4. Statistical Analysis 
All statistics, except the receiver operating characteristic (ROC) 
curve, were performed using SPSS ver. 15.0 (SPSS Inc., Chicago, IL, 
USA). Carotid plaque was dichotomized according to whether or 
not there was carotid plaque. We defined abnormal CCA-IMT as 
the 75th percentile of CCA-IMT, and CCA-IMT was dichotomized 
according to the 75th percentile of CCA-IMT (≤ 0.83 mm or > 
0.83 mm). ABI was dichotomized according to ABI > 0.9 or ABI > 
0.9.
18) Logistic regression was used to compare odds ratios (ORs) for 
FRS, UKPDS, and SCORE risk scores in relation to carotid plaque, 
CCA-IMT, and ABI data. ￿e areas under the curve (AUC) of the 
ROC curves were compared using Stata ver. 10 (StataCorp, College 
Station, TX, USA), and the distribution of the FRS, UKPDS, and 
SCORE risk scores was graphed using kernel density estimation in 
Stata ver. 10. 
RESULTS
1. General Characteristics
￿e general and biochemical characteristics of the 621 subjects 
(194 men and 427 women) are detailed in Table 2. The mean 
(± standard deviation [SD]) age at diabetic diagnosis was 59.2 ± 
12.6 years old, and the mean diabetic duration was 8.9 ± 8.0 years. 
The mean systolic blood pressure (BP) was 130.3 ± 17.8 mmHg, 
and the mean diastolic BP was 71.8 ± 9.8 mmHg. The mean total 
cholesterol was 195.0 ± 43.0 mg/dL, and the mean HDL cholesterol 
was 47.9 ± 11.9 mg/dL. ￿e mean HbA1c level was 7.5 ± 1.6%, and 
missing. HbA1c levels were analyzed via high-performance liquid 
chromatography using a VARIANT II system (BIO-￿D, Hercules, 
CA, USA). 
2. Carotid Plaque, CCA-IMT, and ABI
Well-trained medical doctors performed ultrasonographic 
scanning of the carotid arteries using high-resolution mode B 
ultrasound (SONOACE 9900, Medison, Korea) with an electrical 
linear array transducer (7.5 MHz). The IMT was defined as the 
distance from the leading edge of the first echogenic line to the 
second echogenic line, which indicated the media-adventitia 
interface. Images of the thickest point at the carotid bulb and the 
thickest point within 10 mm from the carotid bulb to the CCA 
were saved as CCA-IMT and then measured using Sigma Scan Pro 
ver. 5.0.0 (SPSS Inc., Chicago, IL, USA). The examiners evaluated 
the CCA, carotid bulb, and internal carotid artery to determine the 
amount of carotid plaque. Protrusions into the lumen that were 100% 
thicker than the nearest area were de￿ned as plaque. If the plaque was 
the thickest point, the distance to the nearest point without plaque 
Table 1. Components of the FRS, UKPDS risk engine, and SCORE 
risk equations.
FRS UKPDS risk engine
SCORE risk 
equations
Sex Sex Sex
Age Age at diabetic 
  diagnosis
Age
Total cholesterol
  or LDL
Total cholesterol Total cholesterol
HDL HDL -
Systolic blood 
  pressure
Systolic blood 
  pressure
Systolic blood 
  pressure
Diabetes Diabetes duration -
Smoking Smoking Smoking
- Glycated 
  hemoglobin
-
- Atrial fibrillation -
- Ethnicity -
FRS: Framingham Risk Score, UKPDS: United Kingdom Pros-
pective Diabetes Study, SCORE: Systematic Coronary Risk Evalua-
tion, HDL: high-density lipoprotein, LDL: low-density lipoprotein. Hye-Ran Ahn, et al: Comparison of Risk Scores for Predicting Atherosclerosis
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the mean CCA-IMT was 0.73 ± 0.15 mm. ￿e number of subjects 
whose CCA-IMT was thicker than 75 percentile (0.83 mm) was 
149 (24.7%). ￿e number of current smokers was 95 (15.3%). ￿e 
number of subjects with one more carotid plaques in their carotid 
arteries was 287 (47.0%), and 69 subjects (11.2%) had ABIs < 0.9.
Diabetic duration, height, weight, diastolic BP and fasting plasma 
glucose are higher in males than in females. Age, age at diabetic 
diagnosis, BMI, abdomen circumference, total cholesterol, HDL 
cholesterol and LDL cholesterol are higher in females. Male subjects 
were more likely to smoke, be more present of carotid artery plaque, 
and have an ABI of less than 0.9.
2. Comparison of ORs
￿e ORs of risk scores according to quartiles are listed in Table 
3. ￿e ￿rst quartile of the scores was set as the reference (OR = 1.0). 
The ORs of all risk scores increased as the quartiles increased for 
carotid plaque, CCA-IMT, and ABI. For carotid plaque, the UKPDS 
risk score provided the highest OR (95% con￿dence interval [CI]) 
at 3.82 (2.36, 6.17). For CCA-IMT, the UKPDS risk score provided 
the highest OR (95% CI) at 6.21 (3.37, 11.45). For ABI, the SCORE 
risk estimation provided the highest OR (95% CI) at 7.41 (3.20, 
17.18). 
Table 2. General characteristics of subjects.
Variable Total Male Female P-value
Total number     621 (100.0) 194 (31.2)    427 (68.8)     -
Age (y)    68.1 ± 10.3  65.2 ± 10.4     69.4 ± 10.1  <0.001
Age at diabetic diagnosis (y)   59.2 ± 12.6   55.1 ± 12.7     61.2 ± 12.1  <0.001
Diabetic duration (y)   8.9 ± 8.0  10.1 ± 8.4     8.3 ± 7.8  0.007
Height (cm) 154.5 ± 8.6  163.7 ± 6.6  150.4 ± 5.7  <0.001
Weight (kg) 58.3 ± 9.7 61.5 ± 9.8 56.9 ± 9.4 <0.001
Body mass index (kg/m
2) 24.4 ± 3.7  23.0 ± 3.2  25.1 ± 3.8  <0.001
Abdomen circumference (cm) 88.7 ± 9.5  86.5 ± 8.1  89.7 ± 9.9  <0.001
Systolic blood pressure (mmHg) 130.3 ± 17.8  131.8 ± 19.2  129.6 ± 17.1  0.161
Diastolic blood pressure (mmHg) 71.8 ± 9.8    73.7 ± 10.2  70.9 ± 9.5  0.001
Total cholesterol (mg/dL) 195.0 ± 43.0  183.7 ± 43.4  200.1 ± 42.0  <0.001
Triglycerides (mg/dL) 182.5 ± 87.4    180.7 ± 118.8  183.3 ± 68.8  0.739
HDL cholesterol (mg/dL)    47.9 ± 11.9    46.1 ± 12.5     48.7 ± 11.6  0.011
LDL cholesterol (mg/dL) 111.4 ± 34.6  102.9 ± 32.9  115.1 ± 34.8  <0.001
Fasting plasma glucose (mg/dL) 137.6 ± 50.3  145.5 ± 61.9  134.0 ± 43.7  0.008
Glycated hemoglobin (%)   7.5 ± 1.6    7.5 ± 1.9     7.4 ± 1.5  0.675
CCA-IMT (mm)   0.73 ± 0.15    0.74 ± 0.17     0.73 ± 0.14  0.650
CCA-IMT > 75 percentile (0.83 mm)    149 (24.7)    45 (23.9)    104 (25.1) 0.767
Current smoker        95 (15.3)   78 (40.2)   17 (4.0) <0.001
Carotid plaque     287 (47.0) 102 (54.0)   185 (43.9) 0.022
ABI ≤ 0.9       69 (11.2)     30 (15.5)   39 (9.3) 0.022
Values are given as the mean ± standard deviation or number (%).
HDL: high-density lipoprotein, LDL: low-density lipoprotein, CCA: common carotid artery, IMT: intima-media thickness, PAD: peripheral 
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respectively). 
4. Kernel Density Distribution
The Kernel density distributions of the FRS, UKPDS, and 
SCORE risk scores are showed in Figure 1. ￿e Kernel density of the 
FRS, UKPDS, and SCORE is highest at 2.0, 15.0, and 1.7, respec-
tively. UKPDS showed a higher risk score distribution than FRS or 
SCORE.
DISCUSSION
We compared the predictability of the FRS, UKPDS risk engine, 
and SCORE risk estimation for carotid atherosclerosis and PAD in 
Korean type 2 diabetic patients. ￿e ORs of all risk scores increased 
as the quartiles increased for carotid plaque, CCA-IMT, and ABI. 
When we compared the predictability of these three risk scores 
according to the carotid plaque, CCA-IMT, and ABI, no signi￿cant 
di￿erence was detected. 
3. Comparison of AUCs
Comparisons of the AUC for the FRS, UKPDS, and SCORE risk 
scores according to carotid plaque, CCA-IMT, and ABI are shown 
in Table 4. No significant difference was observed among scores 
for carotid plaque, CCA-IMT, or ABI (P = 0.839, 0.313, and 0.113, 
Table 3. Comparison of odds ratio among FRS, UKPDS, SCORE.
 Carotid plaque
† CCA-IMT
‡ ABI
§
FRS Q1 (<1.2, ref) 1.00 1.00 1.00
Q2 (1.2-5.4) 1.21 (0.76, 1.94) 0.84 (0.45, 1.56) 1.25 (0.48, 3.26)
Q3 (5.5-14.6) 2.18 (1.37, 3.46)** 1.51 (0.86, 2.65) 2.10 (0.87, 5.08)
Q4 (>14.6) 2.97 (1.86, 4.74)* 3.49 (2.05, 5.96)* 5.45 (2.43, 12.21)*
P for trend <0.001 <0.001 <0.001
UKPDS Q1 (<12.5, ref) 1.00 1.00 1.00
Q2 (12.5-19.1) 1.62 (1.01, 2.59)** 1.89 (0.98, 3.67) 0.57 (0.22, 1.48)
Q3 (19.2-28.4) 2.29 (1.43, 3.68)** 3.01 (1.59, 5.68)** 1.20 (0.54, 2.69)
Q4 (>28.4) 3.82 (2.36, 6.17)* 6.21 (3.37, 11.45)* 3.72 (1.85, 7.49)*
P for trend <0.001 <0.001 <0.001
SCORE Q1 (<1.8, ref) 1.00 1.00 1.00
Q2 (1.8-3.4) 1.66 (1.04, 2.66)** 2.13 (1.14, 3.97)** 1.25 (0.48, 3.26)
Q3 (3.5-6.8) 2.14 (1.34, 3.42)** 2.12 (1.13, 3.97)** 2.10 (0.87, 5.08)
Q4 (>6.8) 3.81 (2.36, 6.15)* 5.23 (2.90, 9.43)* 7.41 (3.20, 17.18)*
P for trend <0.001 <0.001 <0.001
FRS: Framingham Risk Score, UKPDS: United Kingdom Prospective Diabetes Study, SCORE, Systematic Coronary Risk Evaluation, CCA: 
common carotid artery, IMT: intima-media thickness, PAD: peripheral arterial disease, ABI: ankle-brachial index. 
*P < 0.001. **P < 0.05. 
†Carotid plaque was dichotomized according to whether there was plaque or not. 
‡CCA-IMT was dichotomized 
according to 75 percentile of IMT (≤ 0.83 mm or > 0.83 mm). 
§ABI was dichotomized according to ABI ≤ 0.9 or ABI > 0.9.
Table 4. Comparison of AUCs among FRS, UKPDS, SCORE.
FRS UKPDS SCORE P-value
Carotid plaque* 0.633 0.643 0.634 0.839
CCA-IMT
† 0.674 0.700 0.674 0.313
ABI
‡ 0.692 0.682 0.725 0.113
AUC: area under the curve, FRS: Framingham Risk Score, UKPDS: 
United Kingdom Prospective Diabetes Study, SCORE: Systematic 
Coronary Risk Evaluation, CCA: common carotid artery, IMT: 
intima-media thickness, ABI: ankle-brachial index.
*Carotid plaque was dichotomized according to whether there was 
plaque or not. 
†CCA-IMT was dichotomized according to 75 
percentile of IMT (≤ 0.83 mm or > 0.83 mm). 
‡ABI was dichoto-
mized according to ABI ≤ 0.9 or ABI > 0.9.Hye-Ran Ahn, et al: Comparison of Risk Scores for Predicting Atherosclerosis
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compared the predictability of the FRS with that of UKPDS risk 
engine. ￿e AUCs of the FRS and UKPDS scores for known diabetes 
patients were 0.60 and 0.61 and there was no signi￿cant di￿erence. 
Similar to our results, the few prospective studies comparing risk 
scores for diabetes patients have reported no significant difference 
among risk scores. 
Others compared the predictability using CVD surrogate 
mea sure similar to our study. In a cross-sectional study, Rakhit et 
al.
29) recruited 199 asymptomatic type 2 diabetes patients from 
the community and a hospital out-patient clinic in Australia and 
compared the predictability of the FRS with that of the UKPDS 
risk engine, based on exercise electrocardiography findings. The 
AUCs of the FRS and UKPDS risk engine were 0.61 and 0.56, 
respectively, with no signi￿cant di￿erence between them. In a study 
that examined Korean patients with type 2 diabetes,
30) the CVD risk 
was be￿er assessed using the FRS than using the UKPDS. ￿is result 
is vastly di￿erent to our results. But they compared the predictability 
between the FRS and the UKPDS based on the high sensitivity 
C-reactive protein (hsCRP). Even though hsCRP is known to 
predict cardiovascular events like ischemic stroke and myocardial 
infarction,
31) hsCRP failed to be an independent risk factor for early 
carotid atherosclerosis.
32)
When we graphed the Kernel density distribution of the three 
risk scores, UKPDS showed a higher risk score distribution than 
FRS or SCORE (Figure 1). Song et al.
33) performed a cross-sectional 
study with 700 diabetes patients classified according to risk based 
on the Joint British Society risk score; these patients were then re-
analyzed according to the FRS and UKPDS score. The authors 
reported that the UKPDS score identi￿ed more patients in the high-
risk group than the FRS. Guzder et al.
26) compared the distribution 
of FRS and UKPDS values and reported that the UKPDS risk engine 
provided higher risk scores than the FRS when the risk scores were 
over 30%, similar to our results. The UKPDS may have generated 
higher risk scores than FRS or SCORE because it was developed 
for risk estimation in a diabetic population, including important 
variables such as diabetic duration and HbA1c level, whereas the 
FRS and SCORE were developed for risk estimation in the general 
population. 
This study possesses the limitations inherent in a cross-
sectional study. We could not observe the CVD events, but instead 
attempted to predict future CVD events based on indicators such 
as CCA-IMT, carotid plaque, and ABI, which are known surrogates 
Previous studies have investigated the association between 
risk scores and carotid plaque and IMT.
19-25) In a cohort study 
of 517 young adults, FRS was independently associated with 
IMT. Consistent with our results, carotid plaque and IMT were 
independently related with the Framingham cardiovascular score in 
an international cross-sectional study of 2,328 subjects (OR, 2.97; 
95% CI, 1.86 to 4.74 for carotid plaque and OR, 3.49; 95% CI, 2.05 
to 5.96 for IMT). Similar to our results, UKPDS was associated with 
carotid plaque,
23) and IMT
22) (OR, 3.82; 95% CI, 2.36 to 6.17 for 
carotid plaque and OR, 6.21; 95% CI, 3.37 to 11.45 for IMT), and 
SCORE was associated with carotid plaque
24) and IMT
25) (OR, 3.81; 
95% CI, 2.36 to 6.15 for carotid plaque and OR, 5.23; 95% CI, 2.90 
to 9.43 for IMT).  
Additional studies have compared the predictability among 
risk scores. Some researchers studied the predictability based on the 
observation of CVD events. Guzder et al.
26) investigated a cohort 
composed of 428 newly diagnosed type 2 diabetes patients without 
clinically evident CVD in the United Kingdom for 4.2 years. They 
compared the predictability of the FRS with that of the UKPDS 
risk engine and reported that the AUCs of the FRS and UKPDS 
were 0.657 and 0.670, respectively. Coleman et al.
27) compared the 
predictability of the FRS and SCORE with the UKPDS in 5,102 
newly diagnosed type 2 patients and reported that the AUCs of 
the FRS and SCORE were similar (0.76 and 0.77, respectively). 
Simmons et al.
28) conducted a population-based cohort study of 
9,000 people who presented to general practices for health exams in 
the United Kingdom. ￿ey observed the subjects for 10.5 years and 
Figure 1. Kernel density distribution of the Framingham Risk Score 
(FRS), United Kingdom Prospective Diabetes Study (UKPDS) risk 
engine, and the Systematic Coronary Risk Evaluation (SCORE) risk 
scores.Hye-Ran Ahn, et al: Comparison of Risk Scores for Predicting Atherosclerosis Hye-Ran Ahn, et al: Comparison of Risk Scores for Predicting Atherosclerosis Hye-Ran Ahn, et al: Comparison of Risk Scores for Predicting Atherosclerosis
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for atherosclerosis. Despite its limitations, this study represents a 
valuable contribution in that it examines Korean type 2 diabetes 
patients, whereas previous CVD risk development and comparison 
studies were limited to European and American subjects. 
In conclusion, this study revealed significant associations bet-
ween risk scores and carotid plaque, CCA-IMT, and ABI; however, 
no significant differences were observed when comparing the 
predictability of the risk scores for carotid atherosclerosis and PAD in 
Korean type 2 diabetic patients. Because the SCORE risk equation is 
simpler than other risk equation, doctors can more easily assess the 
CVD risk of the Korean type 2 diabetic patients using by SCORE 
risk equation. 
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